Detalhe da pesquisa
1.
Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine (R-MIV) in patients with primary CNS lymphoma including recent COVID-19 pandemic experience.
Br J Haematol
; 201(4): 663-672, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36762710
2.
Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia-a real-world analysis of the Polish Adult Leukemia Study Group.
Ann Hematol
; 102(8): 2119-2126, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37392368
3.
Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphoma.
Br J Haematol
; 198(1): 73-81, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35362096
4.
Genetic associations with lymphomas in Polish patients: A pooled-DNA genome-wide association analysis.
Int J Immunogenet
; 49(5): 353-363, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-36036752
5.
Rituximab and Chemotherapy for Newly Diagnosed Follicular Lymphoma: Real-World Report of Polish Lymphoma Research Group.
Chemotherapy
; 67(4): 201-210, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35249035
6.
Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 study.
Lancet Oncol
; 22(4): 512-524, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33721562
7.
High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin Lymphoma.
Ann Hematol
; 100(7): 1755-1767, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33625572
8.
First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4.
Br J Haematol
; 188(6): 898-906, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31792945
9.
Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy.
Br J Haematol
; 183(3): 400-410, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30168134
10.
Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma.
Ann Hematol
; 100(7): 1919, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33760951
11.
Polish Lymphoma Research Group Experience With Bexarotene in the Treatment of Cutaneous T-Cell Lymphoma.
Am J Ther
; 23(3): e749-56, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-24732904
12.
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue of the dura mimicking meningioma: a case report and literature review.
Folia Neuropathol
; 62(1): 102-107, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38741437
13.
Richter transformation - retrospective treatment outcomes analysis in Polish Adult Leukemia Study Group.
Leuk Lymphoma
; 65(2): 175-186, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37921067
14.
New molecular targets in Hodgkin and Reed-Sternberg cells.
Front Immunol
; 14: 1155468, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37266436
15.
A survey across orbital lymphoma in Poland: Multicenter retrospective study of polish lymphoma research group (PLRG).
Cancer Med
; 12(3): 3036-3045, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36161781
16.
Early efficacy and safety of obinutuzumab with chemotherapy in previously untreated patients with follicular lymphoma: A real-world retrospective report of the Polish Lymphoma Research Group.
Adv Clin Exp Med
; 32(1): 131-136, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36603138
17.
High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow up.
Sci Rep
; 12(1): 10551, 2022 06 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35732790
18.
Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma.
Blood Adv
; 6(2): 590-599, 2022 01 25.
Artigo
Inglês
| MEDLINE | ID: mdl-34644372
19.
Outcome of SARS-CoV-2-Infected Polish Patients with Chronic Lymphocytic Leukemia.
Cancers (Basel)
; 14(3)2022 Jan 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35158826
20.
Peripheral Blood Cells from Patients with Hodgkin's and Diffuse Large B Cell Lymphomas May Be a Better Source of Candidate Diagnostic miRNAs Than Circulating miRNAs.
Biomed Res Int
; 2021: 3212878, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33628777